ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Access to Document
Other files and links
Research output: Contribution to journal › Comment/debate › peer-review
TY - JOUR
T1 - Gender equity in interstitial lung disease
AU - Kawano-Dourado, Leticia
AU - Glassberg, Marilyn K.
AU - Molina-Molina, Maria
AU - Strek, Mary E.
AU - Wijsenbeek, Marlies
AU - Johannson, Kerri A.
N1 - Funding Information: MKG serves on the advisory board for Bellerophon Therapeutics. MM-M reports grants and personal fees from Boehringer Ingelheim, Esteve-Teijin, and Roche; personal fees from Galapagos and Pfizer; and grants from GlaxoSmithKline, outside of the submitted work. MES reports grants, personal fees, and non-financial support from Boehringer Ingelheim and grants from Galapagos and Novartis, outside of the submitted work. MW's institution received grants and consultancy fees from Boehringer Ingelheim and Hoffmann-La Roche, and consultancy fees from Galapagos, Novartis, and Respivant, outside of the submitted work. KAJ reports she has served as a consultant to and received personal fees from Blade Therapeutics, Boehringer Ingelheim, Hoffmann-La Roche, and Theravance; grants from Chest Foundation, University of Calgary School of Medicine, Pulmonary Fibrosis Society of Calgary, and UCB Biopharma SPRL; and personal fees from Three Lakes Foundation, outside of the submitted work. LK-D declares no competing interests. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/9
Y1 - 2020/9
UR - http://www.scopus.com/inward/record.url?scp=85089300383&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089300383&partnerID=8YFLogxK
U2 - 10.1016/S2213-2600(20)30310-6
DO - 10.1016/S2213-2600(20)30310-6
M3 - Comment/debate
C2 - 32687800
AN - SCOPUS:85089300383
VL - 8
SP - 842
EP - 843
JO - The Lancet Respiratory Medicine
JF - The Lancet Respiratory Medicine
SN - 2213-2600
IS - 9